Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China

20260 citationsJournal Articlediamond Open Access

Authors

Jinlin Hou · Nanfang Hospital

Qin Ning · Tongji Hospital

Zhongping Duan · Capital Medical University

Yu Chen · Capital Medical University

Qing Xie · Shanghai Jiao Tong University

Lunli Zhang · Nanchang University

Shanming Wu · Shanghai Public Health Clinical Center

Abstract

Long-term TAF treatment demonstrated durable virologic efficacy, sustained biochemical and serological responses, and favorable renal and bone safety over eight years in Chinese participants with chronic hepatitis B.

Topics & Keywords

Hepatitis B Virus Studies HIV/AIDS drug development and treatment Hepatitis C virus research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical and Translational Hepatology

Volume 000, Issue 000, pp. 000-000

DOI: 10.14218/jcth.2025.00438

Field-Weighted Citation Impact: 0.00